Difference between revisions of "Team:Sydney Australia/Parts"

Line 5: Line 5:
 
   <script src="http://code.jquery.com/jquery-2.1.0.min.js"></script>
 
   <script src="http://code.jquery.com/jquery-2.1.0.min.js"></script>
 
   <link href="https://fonts.googleapis.com/css?family=Quicksand" rel="stylesheet">
 
   <link href="https://fonts.googleapis.com/css?family=Quicksand" rel="stylesheet">
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css">
 
  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>
 
<script src="http://code.jquery.com/jquery-2.1.0.min.js"></script>
 
<link href="https://fonts.googleapis.com/css?family=Quicksand:300,400|Roboto:400,400i" rel="stylesheet">
 
 
 
<style>  
 
<style>  
  
Line 200: Line 195:
 
<div class="box1"></div>
 
<div class="box1"></div>
 
<div class="row" style="height:2vw;"></div>
 
<div class="row" style="height:2vw;"></div>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" width="99%" style="width:99.54%;border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
+
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%;border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 
  mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt">
 
  mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt">
  <tbody><tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:18.3pt">
+
  <tbody><tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:19.05pt">
   <td width="100%" colspan="4" style="width:100.0%;border:solid windowtext 1.0pt;
+
   <td width="15%" style="width:15.92%;border:solid windowtext 1.0pt;mso-border-alt:
  mso-border-alt:solid windowtext .5pt;background:#E6BC2E;padding:0cm 5.4pt 0cm 5.4pt;
+
  solid windowtext .5pt;background:#F6D562;padding:0cm 5.4pt 0cm 5.4pt;
   height:18.3pt">
+
   height:19.05pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:18.0pt;font-family:Quicksand;color:#3E3F3F">GOLD<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">PART NAME / NO.<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
</tr>
+
   <td width="12%" style="width:12.88%;border:solid windowtext 1.0pt;border-left:
<tr style="mso-yfti-irow:1;height:18.3pt">
+
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   <td width="21%" style="width:21.4%;border:solid windowtext 1.0pt;border-top:
+
   background:#F6D562;padding:0cm 5.4pt 0cm 5.4pt;height:19.05pt">
   none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">SOURCE<o:p></o:p></span></p>
   background:#F6D562;padding:0cm 5.4pt 0cm 5.4pt;height:18.3pt">
+
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:Quicksand"><o:p>&nbsp;</o:p></span></b></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:Quicksand">PART
+
  NAME <span class="GramE">/ <span style="mso-spacerun:yes">&nbsp;</span>NO.</span><o:p></o:p></span></b></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:Quicksand"><o:p>&nbsp;</o:p></span></b></p>
+
 
   </td>
 
   </td>
   <td width="15%" style="width:15.3%;border-top:none;border-left:none;
+
   <td width="29%" style="width:29.62%;border:solid windowtext 1.0pt;border-left:
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
   background:#F6D562;padding:0cm 5.4pt 0cm 5.4pt;height:19.05pt">
   mso-border-alt:solid windowtext .5pt;background:#F6D562;padding:0cm 5.4pt 0cm 5.4pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">KEY FEATURES<o:p></o:p></span></p>
  height:18.3pt">
+
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:Quicksand">TYPE<o:p></o:p></span></b></p>
+
 
   </td>
 
   </td>
   <td width="15%" style="width:15.6%;border-top:none;border-left:none;
+
   <td width="41%" style="width:41.56%;border:solid windowtext 1.0pt;border-left:
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
   background:#F6D562;padding:0cm 5.4pt 0cm 5.4pt;height:19.05pt">
   mso-border-alt:solid windowtext .5pt;background:#F6D562;padding:0cm 5.4pt 0cm 5.4pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">WHY IS IT GOLD?<o:p></o:p></span></p>
  height:18.3pt">
+
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:Quicksand">SOURCE<o:p></o:p></span></b></p>
+
  </td>
+
  <td width="47%" style="width:47.7%;border-top:none;border-left:none;
+
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
  mso-border-alt:solid windowtext .5pt;background:#F6D562;padding:0cm 5.4pt 0cm 5.4pt;
+
  height:18.3pt">
+
  <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:Quicksand">KEY
+
  FEATURES<o:p></o:p></span></b></p>
+
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
  <tr style="mso-yfti-irow:2;height:11.35pt">
+
  <tr style="mso-yfti-irow:1;height:78.9pt">
   <td width="21%" style="width:21.4%;border:solid windowtext 1.0pt;border-top:
+
   <td width="15%" style="width:15.92%;border:solid windowtext 1.0pt;border-top:
 
   none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
+
   padding:0cm 5.4pt 0cm 5.4pt;height:78.9pt">
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span class="SpellE"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">YncM-Winsulin</span></span><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p></o:p></span></p>
  tab-stops:14.2pt"><span class="SpellE"><span lang="EN-US" style="font-size:13.0pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417005">BBa_K2417005</a><o:p></o:p></span></p>
  font-family:Quicksand">YncM-Winsulin</span></span><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417005">BBa_K2417005</a><o:p></o:p></span></p>
+
 
   </td>
 
   </td>
   <td width="15%" style="width:15.3%;border-top:none;border-left:none;
+
   <td width="12%" style="width:12.88%;border-top:none;border-left:none;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:78.9pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">COMPOSITE PART<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 +
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Bacillus subtilis (<span class="SpellE">YncM</span> secretion tag)<o:p></o:p></span></p>
 +
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
   <td width="15%" style="width:15.6%;border-top:none;border-left:none;
+
   <td width="29%" style="width:29.62%;border-top:none;border-left:none;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:78.9pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l16 level1 lfo12"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
   tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Bacillus
+
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Novel short chain
   subtilis (<span class="SpellE">YncM</span> secretion tag)<o:p></o:p></span></p>
+
   insulin analogue (<span class="SpellE">Winsulin</span>) with a 12AA linker (-QRGGGSGGGQRR-)<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l16 level1 lfo12"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span class="SpellE"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">YncM</span></span><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"> secretion tag to
 +
  translocate protein into media<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l16 level1 lfo12"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">N-terminal 6x His
 +
  Tag purification<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l16 level1 lfo12"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">4x GSS flexible
 +
  linker<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l16 level1 lfo12"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">TEV protease
 +
  cleavage site<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l16 level1 lfo12"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Extended ribosome
 +
  binding site<o:p></o:p></span></p>
 +
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
   <td width="47%" style="width:47.7%;border-top:none;border-left:none;
+
   <td width="41%" valign="top" style="width:41.56%;border-top:none;border-left:
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:78.9pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">We
  tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Novel
+
   demonstrated that it works:<o:p></o:p></span></p>
   short chain insulin analogue (<span class="SpellE">Winsulin</span>) with a 12AA
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l10 level1 lfo19"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
  linker (QRGGGSGGGQRR)<o:p></o:p></span></p>
+
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">We tested it in
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
  insulin-sensitive cell lines and saw an increase in glycogen synthesis and
  tab-stops:14.2pt"><span class="SpellE"><span lang="EN-US" style="font-size:13.0pt;
+
   glucose oxidation above basal levels, proving its bioactivity<br style="mso-special-character:line-break">
   font-family:Quicksand">YncM</span></span><span lang="EN-US" style="font-size:
+
  <!--[if !supportLineBreakNewLine]--><br style="mso-special-character:line-break">
  13.0pt;font-family:Quicksand"> secretion tag to translocate protein into
+
  <!--[endif]--><o:p></o:p></span></p>
  media<o:p></o:p></span></p>
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l10 level1 lfo19"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
  <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">We showed via an
  tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N-terminal
+
   ELISA assay that whilst the cell lysate did not contain <span class="SpellE">Winsulin</span>,
   6x His Tag purification<o:p></o:p></span></p>
+
  the media in which the cells were growing did. <span class="GramE">Therefore</span>
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
  the <span class="SpellE">YncM</span> secretion tag worked as expected<o:p></o:p></span></p>
  tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">4x
+
   <p class="MsoListParagraphCxSpLast"><span lang="EN-US" style="font-size:15.0pt;
   GSS flexible linker<o:p></o:p></span></p>
+
  font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">The
  tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">TEV
+
  results for these assays can be found <a href="https://2017.igem.org/Team:Sydney_Australia/Results">here</a><o:p></o:p></span></p>
   protease cleavage site<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
  tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Extended
+
  ribosome binding site<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
  <tr style="mso-yfti-irow:3;height:114.0pt">
+
  <tr style="mso-yfti-irow:2;height:206.35pt">
   <td width="21%" rowspan="2" style="width:21.4%;border:solid windowtext 1.0pt;
+
   <td width="15%" rowspan="2" style="width:15.92%;border:solid windowtext 1.0pt;
 
   border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   padding:0cm 5.4pt 0cm 5.4pt;height:206.35pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span class="SpellE"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Ecotin</span></span><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">-Proinsulin<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span class="SpellE"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Ecotin</span></span><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">-Proinsulin<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417000">BBa_K2417000</a><o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417000">BBa_K2417000<o:p></o:p></a></span></p>
 +
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
   <td width="15%" rowspan="2" style="width:15.3%;border-top:none;border-left:
+
   <td width="12%" style="width:12.88%;border-top:none;border-left:none;
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">COMPOSITE PART<o:p></o:p></span></p>
+
  </td>
+
  <td width="15%" style="width:15.6%;border-top:none;border-left:none;
+
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:206.35pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">E. Coli (<span class="SpellE">Ecotin</span>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">E. Coli (<span class="SpellE">Ecotin</span>
   Tag)<o:p></o:p></span></p>
+
   tag)<o:p></o:p></span></p>
 
   </td>
 
   </td>
   <td width="47%" rowspan="2" style="width:47.7%;border-top:none;border-left:
+
   <td width="29%" rowspan="2" style="width:29.62%;border-top:none;border-left:
 
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:206.35pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Human proinsulin<o:p></o:p></span></p>
+
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N-terminal <span class="SpellE">Ecotin</span>
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  tag for targeting proteins to the periplasm<o:p></o:p></span></p>
+
  <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l8 level1 lfo13"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N terminal 6x His Tag<o:p></o:p></span></p>
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Human proinsulin<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">4x GSS flexible linker<o:p></o:p></span></p>
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l8 level1 lfo13"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">TEV protease cleavage site<o:p></o:p></span></p>
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">N-terminal <span class="SpellE">Ecotin</span> tag for targeting proteins to the periplasm<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Extended ribosomal binding
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l8 level1 lfo13"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
   site<o:p></o:p></span></p>
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">N-terminal 6x His
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
  tag<o:p></o:p></span></p>
 +
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l8 level1 lfo13"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">4x GGS flexible
 +
  linker<o:p></o:p></span></p>
 +
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l8 level1 lfo13"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">trypsin protease
 +
  cleavage site for His-tag and C-peptide cleavage<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l8 level1 lfo13"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Extended ribosomal
 +
  binding site<o:p></o:p></span></p>
 +
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 +
  </td>
 +
  <td width="41%" rowspan="2" valign="top" style="width:41.56%;border-top:none;
 +
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 +
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 +
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:206.35pt">
 +
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><br style="mso-special-character:line-break">
 +
  <!--[if !supportLineBreakNewLine]--><br style="mso-special-character:line-break">
 +
  <!--[endif]--><o:p></o:p></span></p>
 +
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">We
 +
  improved previous parts:<o:p></o:p></span></p>
 +
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_M39904">BBa_M39904</a> and <a href="http://parts.igem.org/Part:BBa_M1877">BBa_M1877</a> by:<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l4 level1 lfo20"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">completing their
 +
  sequence<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l4 level1 lfo20"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Adding a
 +
  periplasmic transporter tag (for more efficient folding in an oxidative
 +
  environment)<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l4 level1 lfo20"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Adding an efficient
 +
  ribosomal binding site<o:p></o:p></span></p>
 +
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l4 level1 lfo20"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Adding an
 +
  N-terminal His tag for purification<o:p></o:p></span></p>
 +
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 +
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">We
 +
  demonstrated that it works:<o:p></o:p></span></p>
 +
  <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">By testing it
 +
  insulin-sensitive cell lines and saw an increase in glycogen synthesis and
 +
  glucose oxidation above basal levels, therefore proving its bioactivity<o:p></o:p></span></p>
 +
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 +
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">The
 +
  results for these assays can be found <a href="https://2017.igem.org/Team:Sydney_Australia/Results">here</a><o:p></o:p></span></p>
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
  <tr style="mso-yfti-irow:4;height:114.0pt">
+
  <tr style="mso-yfti-irow:3;height:72.85pt">
   <td width="15%" style="width:15.6%;border-top:none;border-left:none;
+
   <td width="12%" style="width:12.88%;border-top:none;border-left:none;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:72.85pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Human (<span class="SpellE">Human</span>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Human (<span class="SpellE">Human</span>
 
   proinsulin)<o:p></o:p></span></p>
 
   proinsulin)<o:p></o:p></span></p>
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
  <tr style="mso-yfti-irow:5;mso-yfti-lastrow:yes;height:114.0pt">
+
  <tr style="mso-yfti-irow:4;mso-yfti-lastrow:yes;height:42.15pt">
   <td width="21%" style="width:21.4%;border:solid windowtext 1.0pt;border-top:
+
   <td width="15%" style="width:15.92%;border:solid windowtext 1.0pt;border-top:
 
   none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   padding:0cm 5.4pt 0cm 5.4pt;height:42.15pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Cytoplasmic-Proinsulin <span style="mso-spacerun:yes">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="http://parts.igem.org/Part:BBa_K2417001">BBa_K2417001</a><o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Cytoplasmic-Proinsulin <span style="mso-spacerun:yes">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="http://parts.igem.org/Part:BBa_K2417001">BBa_K2417001</a><o:p></o:p></span></p>
 
   </td>
 
   </td>
   <td width="15%" style="width:15.3%;border-top:none;border-left:none;
+
   <td width="12%" style="width:12.88%;border-top:none;border-left:none;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:42.15pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">COMPOSITE PART<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Human (<span class="SpellE">Human</span>
 +
  proinsulin)<o:p></o:p></span></p>
 
   </td>
 
   </td>
   <td width="15%" style="width:15.6%;border-top:none;border-left:none;
+
   <td width="29%" style="width:29.62%;border-top:none;border-left:none;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:42.15pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Human (<span class="SpellE">Human</span>
+
  <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
   proinsulin)<o:p></o:p></span></p>
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Human proinsulin<o:p></o:p></span></p>
 +
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">N-terminal 6x His
 +
  tag<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">4x GGS flexible linker<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Trypsin protease
 +
   cleavage site for His-tag and C-peptide cleavage<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Extended ribosomal
 +
  binding site<o:p></o:p></span></p>
 
   </td>
 
   </td>
   <td width="47%" style="width:47.7%;border-top:none;border-left:none;
+
   <td width="41%" valign="top" style="width:41.56%;border-top:none;border-left:
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:42.15pt">
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Human
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">We
   proinsulin<o:p></o:p></span></p>
+
  improved previous parts:<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_M39904">BBa_M39904</a> and <a href="http://parts.igem.org/Part:BBa_M1877">BBa_M1877</a> by:<o:p></o:p></span></p>
   tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N-terminal
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
   6x His tag<o:p></o:p></span></p>
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">completing their
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
   sequence<o:p></o:p></span></p>
   tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">4x
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
   GGS flexible linker<o:p></o:p></span></p>
+
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Adding an efficient
   <p class="MsoNormal" align="center" style="margin-left:7.1pt;text-align:center;
+
   ribosomal binding site<o:p></o:p></span></p>
   tab-stops:14.2pt"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Trypsin
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
   protease cleavage site for His-tag and C-peptide cleavage<o:p></o:p></span></p>
+
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">Adding an
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Extended ribosomal binding
+
   N-terminal His tag for purification<o:p></o:p></span></p>
   site<o:p></o:p></span></p>
+
   <p class="MsoListParagraphCxSpMiddle"><span lang="EN-US" style="font-size:15.0pt;
 +
  font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle"><span lang="EN-US" style="font-size:15.0pt;
 +
  font-family:Quicksand">We demonstrated that it works:<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:15.0pt;font-family:Symbol;mso-fareast-font-family:
 +
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">By testing it insulin-sensitive
 +
   cell lines and saw an increase in glycogen synthesis and glucose oxidation
 +
  above basal levels, therefore proving its bioactivity<o:p></o:p></span></p>
 +
   <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 +
  <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">The
 +
   results for these assays can be found <a href="https://2017.igem.org/Team:Sydney_Australia/Results">here</a><o:p></o:p></span></p>
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
Line 394: Line 443:
 
<div class="row" style="height:2vw;"></div>
 
<div class="row" style="height:2vw;"></div>
 
<div align="center">
 
<div align="center">
 
+
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%;border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" width="99%" style="width:99.54%;border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
+
 
  mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt">
 
  mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt">
  <tbody><tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:18.3pt">
+
  <tbody><tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:67.3pt">
   <td width="21%" style="width:21.4%;border:solid windowtext 1.0pt;mso-border-alt:
+
   <td width="16%" style="width:16.22%;border:solid windowtext 1.0pt;mso-border-alt:
 
   solid windowtext .5pt;background:#CFCFCF;padding:0cm 5.4pt 0cm 5.4pt;
 
   solid windowtext .5pt;background:#CFCFCF;padding:0cm 5.4pt 0cm 5.4pt;
   height:18.3pt">
+
   height:67.3pt">
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  font-family:Quicksand"><o:p>&nbsp;</o:p></span></b></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">PART NAME <span class="GramE">/<span style="mso-spacerun:yes">&nbsp; </span>NO.</span><o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  font-family:Quicksand">PART NAME <span class="GramE">/ <span style="mso-spacerun:yes">&nbsp;</span>NO.</span><o:p></o:p></span></b></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
  font-family:Quicksand"><o:p>&nbsp;</o:p></span></b></p>
+
 
   </td>
 
   </td>
   <td width="15%" style="width:15.3%;border:solid windowtext 1.0pt;border-left:
+
   <td width="12%" style="width:12.56%;border:solid windowtext 1.0pt;border-left:
 
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   background:#CFCFCF;padding:0cm 5.4pt 0cm 5.4pt;height:18.3pt">
+
   background:#CFCFCF;padding:0cm 5.4pt 0cm 5.4pt;height:67.3pt">
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">SOURCE<o:p></o:p></span></p>
  font-family:Quicksand">TYPE<o:p></o:p></span></b></p>
+
 
   </td>
 
   </td>
   <td width="15%" style="width:15.6%;border:solid windowtext 1.0pt;border-left:
+
   <td width="30%" style="width:30.12%;border:solid windowtext 1.0pt;border-left:
 
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   background:#CFCFCF;padding:0cm 5.4pt 0cm 5.4pt;height:18.3pt">
+
   background:#CFCFCF;padding:0cm 5.4pt 0cm 5.4pt;height:67.3pt">
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">KEY FEATURES<o:p></o:p></span></p>
  font-family:Quicksand">SOURCE<o:p></o:p></span></b></p>
+
 
   </td>
 
   </td>
   <td width="47%" style="width:47.7%;border:solid windowtext 1.0pt;border-left:
+
   <td width="41%" style="width:41.1%;border:solid windowtext 1.0pt;border-left:
 
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   background:#CFCFCF;padding:0cm 5.4pt 0cm 5.4pt;height:18.3pt">
+
   background:#CFCFCF;padding:0cm 5.4pt 0cm 5.4pt;height:67.3pt">
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">WHY IS IT SILVER?<o:p></o:p></span></p>
  font-family:Quicksand">KEY FEATURES<o:p></o:p></span></b></p>
+
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
  <tr style="mso-yfti-irow:1;height:11.35pt">
+
  <tr style="mso-yfti-irow:1;mso-yfti-lastrow:yes;height:11.35pt">
   <td width="21%" style="width:21.4%;border:solid windowtext 1.0pt;border-top:
+
   <td width="16%" style="width:16.22%;border:solid windowtext 1.0pt;border-top:
 
   none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
 
   padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Cytoplasmic-<span class="SpellE">Winsulin</span><o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Cytoplasmic-<span class="SpellE">Winsulin</span><o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417003">BBa_K2417003</a><o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417003">BBa_K2417003</a><o:p></o:p></span></p>
 
   </td>
 
   </td>
   <td width="15%" style="width:15.3%;border-top:none;border-left:none;
+
   <td width="12%" style="width:12.56%;border-top:none;border-left:none;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">COMPOSITE PART<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  </td>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">N/A </span><span lang="EN-US" style="font-size:14.0pt;font-family:Helvetica;mso-fareast-font-family:Helvetica;
  <td width="15%" style="width:15.6%;border-top:none;border-left:none;
+
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N/A </span><span lang="EN-US" style="font-size:13.0pt;font-family:Helvetica;mso-fareast-font-family:Helvetica;
+
 
   mso-bidi-font-family:Helvetica">–</span><span lang="EN-US" style="font-size:
 
   mso-bidi-font-family:Helvetica">–</span><span lang="EN-US" style="font-size:
   13.0pt;font-family:Quicksand"> <span class="SpellE">Winsulin</span> is <span class="SpellE">self designed</span> from literature and mammalian insulins<o:p></o:p></span></p>
+
   14.0pt;font-family:Quicksand"> <span class="SpellE">Winsulin</span> is <span class="SpellE">self designed</span> from literature and mammalian insulins<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
   <td width="47%" style="width:47.7%;border-top:none;border-left:none;
+
   <td width="30%" style="width:30.12%;border-top:none;border-left:none;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Novel single chain insulin
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
   analogue (<span class="SpellE">Winsulin</span>) with a 12AA linker
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Novel single chain
 +
   insulin analogue (<span class="SpellE">Winsulin</span>) with a 12AA linker
 
   (QRGGGSGGGQRR)<o:p></o:p></span></p>
 
   (QRGGGSGGGQRR)<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N-terminal 6x His Tag<o:p></o:p></span></p>
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">4x GSS flexible linker<o:p></o:p></span></p>
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">N-terminal 6x His
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">TEV protease cleavage site<o:p></o:p></span></p>
+
  Tag<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Extended ribosome binding site<o:p></o:p></span></p>
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">4x GSS flexible
 +
  linker<o:p></o:p></span></p>
 +
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">TEV protease
 +
  cleavage site<o:p></o:p></span></p>
 +
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Extended ribosome
 +
  binding site<o:p></o:p></span></p>
 +
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
</tr>
+
   <td width="41%" valign="top" style="width:41.1%;border-top:none;border-left:
<tr style="mso-yfti-irow:2;height:114.0pt">
+
   <td width="21%" rowspan="2" style="width:21.4%;border:solid windowtext 1.0pt;
+
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
+
  padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
  <p class="MsoNormal" align="center" style="text-align:center"><span class="SpellE"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Ecotin</span></span><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">-Proinsulin<o:p></o:p></span></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417000">BBa_K2417000</a><o:p></o:p></span></p>
+
  </td>
+
  <td width="15%" rowspan="2" style="width:15.3%;border-top:none;border-left:
+
 
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:11.35pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">COMPOSITE PART<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  </td>
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  <td width="15%" style="width:15.6%;border-top:none;border-left:none;
+
   <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l12 level1 lfo22"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">We validated our
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
  parts by showing that they work in producing insulin. We performed an ELISA
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
  assay testing for properly folded insulin, and detected the presence of
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">E. Coli (<span class="SpellE">Ecotin</span>
+
  Cytoplasmic <span class="SpellE">Winsulin</span>.<o:p></o:p></span></p>
  Tag)<o:p></o:p></span></p>
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   </td>
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  <td width="47%" rowspan="2" style="width:47.7%;border-top:none;border-left:
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand">The
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   results for the assay can be found <a href="https://2017.igem.org/Team:Sydney_Australia/Results">here</a><o:p></o:p></span></p>
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:15.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Human proinsulin<o:p></o:p></span></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N-terminal <span class="SpellE">Ecotin</span>
+
  tag for targeting proteins to the periplasm<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N terminal 6x His Tag<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">4x GSS flexible linker<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">TEV protease cleavage site<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Extended ribosomal binding
+
  site<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
  </td>
+
</tr>
+
<tr style="mso-yfti-irow:3;mso-yfti-lastrow:yes;height:114.0pt">
+
  <td width="15%" style="width:15.6%;border-top:none;border-left:none;
+
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:114.0pt">
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Human (Human proinsulin)<o:p></o:p></span></p>
+
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
Line 521: Line 540:
 
<div class="box3"></div>
 
<div class="box3"></div>
 
<div class="row" style="height:2vw;"></div>
 
<div class="row" style="height:2vw;"></div>
 +
<div align="center">
 +
 
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%;border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%;border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 
  mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt">
 
  mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt">
 
  <tbody><tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:4.75pt">
 
  <tbody><tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:4.75pt">
   <td width="100%" colspan="4" style="width:100.0%;border:solid windowtext 1.0pt;
+
   <td width="16%" style="width:16.22%;border:solid windowtext 1.0pt;mso-border-alt:
  mso-border-alt:solid windowtext .5pt;background:#A36952;padding:0cm 5.4pt 0cm 5.4pt;
+
  solid windowtext .5pt;background:#CD8B65;padding:0cm 5.4pt 0cm 5.4pt;
 
   height:4.75pt">
 
   height:4.75pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:18.0pt;font-family:Quicksand">BRONZE<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">PART NAME / NO.<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
</tr>
+
   <td width="12%" style="width:12.48%;border:solid windowtext 1.0pt;border-left:
<tr style="mso-yfti-irow:1;height:4.75pt">
+
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   <td width="21%" style="width:21.16%;border:solid windowtext 1.0pt;border-top:
+
   none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
+
 
   background:#CD8B65;padding:0cm 5.4pt 0cm 5.4pt;height:4.75pt">
 
   background:#CD8B65;padding:0cm 5.4pt 0cm 5.4pt;height:4.75pt">
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">SOURCE<o:p></o:p></span></p>
  font-family:Quicksand"><o:p>&nbsp;</o:p></span></b></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
  font-family:Quicksand">PART NAME / NO.<o:p></o:p></span></b></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
  font-family:Quicksand"><o:p>&nbsp;</o:p></span></b></p>
+
 
   </td>
 
   </td>
   <td width="15%" style="width:15.14%;border-top:none;border-left:none;
+
   <td width="30%" style="width:30.2%;border:solid windowtext 1.0pt;border-left:
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
   background:#CD8B65;padding:0cm 5.4pt 0cm 5.4pt;height:4.75pt">
   mso-border-alt:solid windowtext .5pt;background:#CD8B65;padding:0cm 5.4pt 0cm 5.4pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">KEY FEATURES<o:p></o:p></span></p>
  height:4.75pt">
+
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
  font-family:Quicksand">TYPE<o:p></o:p></span></b></p>
+
 
   </td>
 
   </td>
   <td width="15%" style="width:15.4%;border-top:none;border-left:none;
+
   <td width="41%" style="width:41.1%;border:solid windowtext 1.0pt;border-left:
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
   background:#CD8B65;padding:0cm 5.4pt 0cm 5.4pt;height:4.75pt">
   mso-border-alt:solid windowtext .5pt;background:#CD8B65;padding:0cm 5.4pt 0cm 5.4pt;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">WHY IS IT BRONZE?<o:p></o:p></span></p>
  height:4.75pt">
+
  <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
  font-family:Quicksand">SOURCE<o:p></o:p></span></b></p>
+
  </td>
+
  <td width="48%" style="width:48.3%;border-top:none;border-left:none;
+
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
+
   mso-border-alt:solid windowtext .5pt;background:#CD8B65;padding:0cm 5.4pt 0cm 5.4pt;
+
  height:4.75pt">
+
   <p class="MsoNormal" align="center" style="text-align:center"><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:13.0pt;
+
  font-family:Quicksand">KEY FEATURES<o:p></o:p></span></b></p>
+
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
  <tr style="mso-yfti-irow:2;height:35.15pt">
+
  <tr style="mso-yfti-irow:1;height:35.15pt">
   <td width="21%" rowspan="2" style="width:21.16%;border:solid windowtext 1.0pt;
+
   <td width="16%" rowspan="2" style="width:16.22%;border:solid windowtext 1.0pt;
 
   border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   padding:0cm 5.4pt 0cm 5.4pt;height:35.15pt">
 
   padding:0cm 5.4pt 0cm 5.4pt;height:35.15pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span class="SpellE"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Ecotin-Winsulin</span></span><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span class="SpellE"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Ecotin-Winsulin</span></span><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417002">BBa_K2417002</a><o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417002">BBa_K2417002</a><o:p></o:p></span></p>
 
   </td>
 
   </td>
   <td width="15%" rowspan="2" style="width:15.14%;border-top:none;border-left:
+
   <td width="12%" style="width:12.48%;border-top:none;border-left:none;
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:35.15pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:35.15pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">COMPOSITE PART<o:p></o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 +
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">E. Coli (<span class="SpellE">Ecotin</span>
 +
  Tag)<o:p></o:p></span></p>
 +
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
   <td width="15%" style="width:15.4%;border-top:none;border-left:none;
+
   <td width="30%" rowspan="2" style="width:30.2%;border-top:none;border-left:
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
+
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:35.15pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:35.15pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l5 level1 lfo23"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">E. Coli (<span class="SpellE">Ecotin</span>
+
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Novel single chain
   Tag)<o:p></o:p></span></p>
+
  insulin analogue (<span class="SpellE">Winsulin</span>) with a 12AA linker (QRGGGSGGGQRR)<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l5 level1 lfo23"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">N-terminal <span class="SpellE">Ecotin</span> tag for targeting proteins to the periplasm<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l5 level1 lfo23"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">N-terminal 6x His
 +
   Tag<o:p></o:p></span></p>
 +
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l5 level1 lfo23"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">4x GSS flexible
 +
  linker<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l5 level1 lfo23"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">TEV protease
 +
  cleavage site<o:p></o:p></span></p>
 +
  <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l5 level1 lfo23"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 +
  Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Extended ribosome
 +
  binding site<o:p></o:p></span></p>
 
   </td>
 
   </td>
   <td width="48%" rowspan="2" style="width:48.3%;border-top:none;border-left:
+
   <td width="41%" rowspan="2" style="width:41.1%;border-top:none;border-left:
 
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:35.15pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:35.15pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Novel single chain insulin
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">We submitted this DNA part to
   analogue (<span class="SpellE">Winsulin</span>) with a 12AA linker
+
   the registry, for other teams to use in the future<o:p></o:p></span></p>
  (QRGGGSGGGQRR)<o:p></o:p></span></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N-terminal <span class="SpellE">Ecotin</span>
+
  tag for targeting proteins to the periplasm<o:p></o:p></span></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N-terminal 6x His Tag<o:p></o:p></span></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">4x GSS flexible linker<o:p></o:p></span></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">TEV protease cleavage site<o:p></o:p></span></p>
+
  <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">Extended ribosome binding site<o:p></o:p></span></p>
+
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
  <tr style="mso-yfti-irow:3;mso-yfti-lastrow:yes;height:18.0pt">
+
  <tr style="mso-yfti-irow:2;mso-yfti-lastrow:yes;height:18.0pt">
   <td width="15%" style="width:15.4%;border-top:none;border-left:none;
+
   <td width="12%" style="width:12.48%;border-top:none;border-left:none;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:18.0pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:18.0pt">
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand">N/A </span><span lang="EN-US" style="font-size:13.0pt;font-family:Helvetica;mso-fareast-font-family:Helvetica;
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">N/A </span><span lang="EN-US" style="font-size:14.0pt;font-family:Helvetica;mso-fareast-font-family:Helvetica;
 
   mso-bidi-font-family:Helvetica">–</span><span lang="EN-US" style="font-size:
 
   mso-bidi-font-family:Helvetica">–</span><span lang="EN-US" style="font-size:
   13.0pt;font-family:Quicksand"> <span class="SpellE">Winsulin</span> is <span class="SpellE">self designed</span> from literature and mammalian insulins<o:p></o:p></span></p>
+
   14.0pt;font-family:Quicksand"> <span class="SpellE">Winsulin</span> is <span class="SpellE">self designed</span> from literature and mammalian insulins<o:p></o:p></span></p>
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:13.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
   <p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   </td>
 
   </td>
 
  </tr>
 
  </tr>
 
</tbody></table>
 
</tbody></table>
 +
</div>
 +
 
</div>
 
</div>
 
</div>
 
</div>

Revision as of 10:07, 30 October 2017

GOLD

 

PART NAME / NO.

 

SOURCE

KEY FEATURES

WHY IS IT GOLD?

YncM-Winsulin

BBa_K2417005

 

Bacillus subtilis (YncM secretion tag)

 

 

·      Novel short chain insulin analogue (Winsulin) with a 12AA linker (-QRGGGSGGGQRR-)

·      YncM secretion tag to translocate protein into media

·      N-terminal 6x His Tag purification

·      4x GSS flexible linker

·      TEV protease cleavage site

·      Extended ribosome binding site

 

 

We demonstrated that it works:

·      We tested it in insulin-sensitive cell lines and saw an increase in glycogen synthesis and glucose oxidation above basal levels, proving its bioactivity

·      We showed via an ELISA assay that whilst the cell lysate did not contain Winsulin, the media in which the cells were growing did. Therefore the YncM secretion tag worked as expected

 

The results for these assays can be found here

Ecotin-Proinsulin

BBa_K2417000

 

E. Coli (Ecotin tag)

 

 

 

·      Human proinsulin

·      N-terminal Ecotin tag for targeting proteins to the periplasm

·      N-terminal 6x His tag

·      4x GGS flexible linker

·      trypsin protease cleavage site for His-tag and C-peptide cleavage

·      Extended ribosomal binding site

 



We improved previous parts:

BBa_M39904 and BBa_M1877 by:

·      completing their sequence

·      Adding a periplasmic transporter tag (for more efficient folding in an oxidative environment)

·      Adding an efficient ribosomal binding site

·      Adding an N-terminal His tag for purification

 

We demonstrated that it works:

·      By testing it insulin-sensitive cell lines and saw an increase in glycogen synthesis and glucose oxidation above basal levels, therefore proving its bioactivity

 

The results for these assays can be found here

Human (Human proinsulin)

Cytoplasmic-Proinsulin     BBa_K2417001

Human (Human proinsulin)

·      Human proinsulin

·      N-terminal 6x His tag

·      4x GGS flexible linker

·      Trypsin protease cleavage site for His-tag and C-peptide cleavage

·      Extended ribosomal binding site

 

We improved previous parts:

BBa_M39904 and BBa_M1877 by:

·      completing their sequence

·      Adding an efficient ribosomal binding site

·      Adding an N-terminal His tag for purification

 

We demonstrated that it works:

·      By testing it insulin-sensitive cell lines and saw an increase in glycogen synthesis and glucose oxidation above basal levels, therefore proving its bioactivity

 

The results for these assays can be found here

SILVER

 

PART NAME /  NO.

 

SOURCE

KEY FEATURES

WHY IS IT SILVER?

Cytoplasmic-Winsulin

BBa_K2417003

 

N/A Winsulin is self designed from literature and mammalian insulins

 

 

·      Novel single chain insulin analogue (Winsulin) with a 12AA linker (QRGGGSGGGQRR)

·      N-terminal 6x His Tag

·      4x GSS flexible linker

·      TEV protease cleavage site

·      Extended ribosome binding site

 

 

 

·      We validated our parts by showing that they work in producing insulin. We performed an ELISA assay testing for properly folded insulin, and detected the presence of Cytoplasmic Winsulin.

 

 

The results for the assay can be found here

 

 

BRONZE

 

PART NAME / NO.

 

SOURCE

KEY FEATURES

WHY IS IT BRONZE?

Ecotin-Winsulin

BBa_K2417002

 

E. Coli (Ecotin Tag)

 

·      Novel single chain insulin analogue (Winsulin) with a 12AA linker (QRGGGSGGGQRR)

·      N-terminal Ecotin tag for targeting proteins to the periplasm

·      N-terminal 6x His Tag

·      4x GSS flexible linker

·      TEV protease cleavage site

·      Extended ribosome binding site

We submitted this DNA part to the registry, for other teams to use in the future

 

N/A Winsulin is self designed from literature and mammalian insulins